Overview

More than half a million people worldwide are now sustained by renal replacement therapy, mainly hemodialysis at a cost exceeding USD 30 billion per year. Each case of ESRD that is delayed or prevented saves funds that may be applied to other aspects of health care. Edited by an internationally renowned nephrologist, Prognosis for Kidney Disorders provides a timely summary of exciting work in progress directed toward renoprotection and of ultimate interdiction of ESRD. Suitable for researchers and clinicians, Dr. Morrell Michael Avram has collected and commented on promising initiatives likely to enter everyday practice in the immediate future. Suitable for renal trainees, experienced kidney doctors, nurses, nutritionists and cardiologists.

Full Product Details

Author:   M.M. Avram
Publisher:   Springer
Imprint:   Springer
Edition:   Softcover reprint of the original 1st ed. 2002
Dimensions:   Width: 17.80cm , Height: 0.80cm , Length: 25.40cm
Weight:   0.387kg
ISBN:  

9789048161645

ISBN 10:   9048161649
Pages:   134
Publication Date:   08 December 2010
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1. How to Achieve Maximal Renoprotection in Non-Diabetic Chronic Renal Disease.- 2. Anemia of Chronic Kidney Disease and its Management with Recombinant Human Erythropoietin and Darbepoetin Alfa.- 3. Cardiovascular Disease in Patients with Chronic Kidney Disease: The Causes and Effects.- 4. Metabolic Pathogenesis of Cardio-Renal Disease.- 5. Oxidative Stress and Inflammation in Hemodialysis Patients.- 6. Prognostic Value of Enrollment Parathyroid Hormone in Hemodialysis and Peritoneal Dialysis Patients for Survival. A 14 years Follow-up.- 7. Prealbumin as an Important Predictor for Survival and Nutritional Status in Hemodialysis and Peritoneal Dialysis Patients.- 8. How to Attain Optimal Antiproteinuric Dose of Losartan in Non-Diabetic Patients with Nephrotic Range Proteinuria.- 9. Hypoalbuminemia in the Patient with Renal Disease: Its Causes and Consequences.- 10. Kidney Disease and Mechanisms that Cause Loss of Muscle Mass.- 11. Role of Plasma Homocysteine and Plasminogen Activator Inhibitor-1 in the Progression of Diabetic Nephropathy.- 12. Effects of Erythropoietin (EPO) and Aminoguanidine (AG) on Deformability (df) in Diabetic Azotemic and Uremic Patients.- 13. Characterization of the PKD1 Gene Product, Polycystin-1.- 14. Nutrition and Blood Pressure.- 15. How to Minimize Bone Disease in Renal Failure.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions